Sanochemia Pharmazeutika AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanochemia Pharmazeutika AG with three other
pharmaceutical manufacturers in Europe:
sales of 31.21 million Euro [US$34.45 million]
of which 56%
was Sale of Goods),
Summit Therapeutics PLC
of the United Kingdom
(£25.42 million [US$32.14 million]
of which 100%
was Drug Discovery), and
Les Trois Chenes
based in France
(35.45 million Euro [US$39.12 million]
During the year ended September of 2018, sales at
Sanochemia Pharmazeutika AG were 33.03 million Euro (US$36.45 million).
decrease of 20.2%
versus 2017, when the company's sales were 41.36 million Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Sanochemia Pharmazeutika AG had sales
of 33.30 million Euro.
Contributing to the drop in overall sales was the 38.5% decline
in Production, from 7.85 million Euro to 4.83 million Euro.
There were also decreases in sales in
Human Pharmaceuticals (down 20.6% to 21.07 million Euro)
Veterinary Pharmaceuticals (down 26.2% to 4.86 million Euro)
However, these declines were partially offset by the increase in sales of
R&d (up 617.7% to 3.09 million Euro)